J.-G. Luo et al. / Bioorg. Med. Chem. 16 (2008) 2912–2920
2919
1
H NMR (500 MHz, pyridine-d ) d 0.79, 0.86, 0.87,
actose (tR 7.538 min), and D-glucose (tR 8.032 min)
derivatives prepared in the same way, respectively.
5
1
3
5
.03, 1.24, 1.40 (3H each, s, Me-25, 29, 30, 26, 27, 24),
.10 (1H, br d, J = 14.0 Hz, 18-H), 4.02 (1H, m, 3-H),
.38 (1H, t-like, 12-H), 9.90 (1H, s, 23-H); C NMR
1
3
3.4.1. 3-Keto, 16a-hydroxy, 24-noroleanolic acid (2a). An
1
13
25
ꢂ
KBr
max
ESIMS m/z: 457
data of the aglycone, see Table 1. H and C NMR data
of glycosidic part, see Table 3. ESIMS m/z: 1231
[MꢀH] ; HRESIMS m/z: 1231.5715 [MꢀH] (calcd
for C H O , 1231.5753).
amorphous solid, ½aꢁ þ 30:5 (c 0.10; CHCl ); IRm
D
3434, 1778, 1706, 1457 cm
[M + H] . H NMR (500 MHz, CDCl ) d 0.84, 0.85,
3
ꢀ
1
;
ꢀ
ꢀ
+
1
3
0.91, 1.12, 1.14 (3H each, s, Me-30, 26, 29, 25, 27-
H), 1.00 (3H, d, J = 6.5 Hz, 23-H) 2.54 (1H, t,
J = 14.0 Hz, H-19), 3.23 (1H, dd, J = 3.3, 14.0 Hz,
5
9
91 27
2
D
5
ꢂ
3
.3.6. Compound 6. White powder; ½aꢁ þ 4:8 (c 0.05;
KBr
max
ꢀ1
.
MeOH); IRm : 3429, 2929, 1731, 1633, 1074 cm
18-H), 5.12 (1H, br s, H-16), 5.34 (1H, t-like, 12-H);
1
13
H NMR (500 MHz, pyridine-d ) d 0.73, 0.82, 0.84,
C NMR (125 MHz, CDCl ) d 40.2 (C-1), 37.4 (C-
5
3
1
3
.01, 1.22, 1.40 (3H each, s, Me-25, 30, 29, 26, 27, 24),
.05 (1H, br d, J = 14.0 Hz, 18-H), 4.03 (1H, m, 3-H),
2), 213.6 (C-3), 44.8 (C-4), 53.7 (C-5), 24.0 (C-6),
31.7 (C-7), 39.2 (C-8), 45.4 (C-9), 36.7 (C-10), 22.1
(C-11), 122. 6 (C-12), 143.9 (C-13), 41.9 (C-14), 36.0
(C-15), 74.1 (C-16), 48.6 (C-17), 41.3 (C-18), 46.9
(C-19), 30.7 (C-20), 35.9 (C-21), 32.4 (C-22), 11.7
(C-23), 13.2 (C-25), 17.1 (C-26), 26.8 (C-27), 180.6
(C-28), 33.1 (C-29), 23.6 (C-30).
1
.36 (1H, t-like, 12-H), 9.91 (1H, s, 23-H); C NMR
3
5
data of the aglycone, see Table 1. H and C NMR data
of glycosidic part, see Table 3. ESIMS m/z: 1495
[MꢀH] , HRESIMS m/z: 1495.6571 [MꢀH] (calcd
for C H O , 1495.6598).
1
13
ꢀ
ꢀ
6
9
107 35
2
5
ꢂ
3
.3.7. Compound 7. White powder; ½aꢁ ꢀ 1:5 (c 0.20;
D
3440, 1734, 1041 cm
3.5. Enzyme inhibition assay
KBr
max
ꢀ1
1
MeOH); IRm
.
H NMR
(
500 MHz, pyridine-d ) d 0.86, 0.87, 0.89, 1.10, 1.21,
5
The a-glucosidase inhibition assay was performed
according to the slightly modified method of Pierre
et al. a-Glucosidase (E.C.3.2.1.20) was purchased
1.52 (3H each, s, Me-25, 29, 30, 26, 27, 24), 3.09 (1H,
br d, J = 14.0 Hz, 18-H), 4.05 (1H, m, 3-H), 5.36 (1H,
13
1
3
t-like, 12-H), 9.93 (1H, s, 23-H); C NMR data of the
from Sigma company (No. G-5003, Lot. 081k7415).
The inhibition was measured spectro-photometrically
at pH 6.8 and at 37 ꢁC for 10 min, using 0.01 M p-nitro-
phenyl a-D-glucopyranoside (PNPG) as a substrate and
1 U/mL of enzyme, in 0.067 M KH PO –Na HPO buf-
1 13
aglycone, see Table 1. H and C NMR data of glyco-
ꢀ
sidic part, see Table 3. ESIMS m/z: 1567 [MꢀH] ,
HRESIMS m/z: 1567.6743 [MꢀH]ꢀ (calcd for
C H O , 1567.6809).
111 37
7
2
2
4
2
4
fer. Acarbose were used as positive controls. The incre-
ment in absorption at 410 nm due to the hydrolysis of
PNPG by a-glucosidase was monitored continuously
with an auto multi-functional microplate reader (BIO-
RAD680).
3
.4. Acid hydrolysis and sterochemistry of sugars of 1–7
Each compound (5 mg) was heated in 2 M HCl (5 mL)
at 90 ꢁC for 4 h. The reaction mixture was extracted
with EtOAc (3 · 5 mL). The EtOAc extract was purified
by chromatography on Sephadex LH-20 (2.0 · 100 cm).
Comparing TLC with authentic samples, the aglycone
Acknowledgment
of 1 was determined to be quillaic acid (1a, R : 0.25,
f
CHCl –MeOH, 20:1), while those of 4–7 were gypsoge-
3
This research work was supported by the National Nat-
ural Science Foundation of China for Outstanding
Young Scientists (No. 30525032).
nin (4a, R : 0.43, CHCl –MeOH, 20:1). In addition,
f
3
3
tained from 2 and 3. The H O layer was concentrated
-keto, 16a-hydroxy, 24-noroleanolic acid (2a) was ob-
2
under reduced pressure to dryness, to give a residue of
the sugar fraction. The residue was dissolved in pyridine
References and notes
(
0.1 mL), to which 0.08 M L-cysteine methyl ester
hydrochloride in pyridine (0.15 mL) was added. The
mixture was kept at 60 ꢁC for 1.5 h. After the reaction
mixture was dried in vacuo, the residue was trimethylsi-
lylated with 1-trimethylsilylimidazole (0.1 mL) for 2 h.
The mixture was partitioned between n-hexane and
1
2
. The Chinese Medicine Dictionary, Shanghai People’s
Publishing House, Shanghai, 1977; p 2170.
. (a) Liu, Z.; Li, D.; Owen, N. L.; Grant, D. M.;
Gates, R. G.; Jia, Z. J. Nat. Prod. 1995, 58, 1632; (b)
Luo, J. G.; Kong, L. Y.; Takaya, Y.; Niwa, M.
Chem. Pharm. Bull. 2006, 54, 1200–1202; (c) Luo, J.
G.; Kong, L. Y. Helv. Chim. Acta 2006, 89, 947–953;
(d) Luo, J. G.; Wang, X. B.; Ma, L.; Kong, L. Y.
Bioorg. Med. Chem. Lett. 2007, 17, 4460–4463; (e)
Zheng, Q.; Li, W.; Han, L.; Koike, K. Chem. Pharm.
Bull. 2007, 55, 646–650.
H O (0.3 mL each) and the n-hexane extract was ana-
2
lyzed by GC–MS (Varian 3800GC, Varian 2200MS,
7
0 eV) under the following conditions: capillary column,
SE30 (30 m · 0.25 mm · 0.25 lm); the column tempera-
ture, 170–250 ꢁC with the rate of 5 ꢁC/min. The carrier
gas: N (30 mL/min). In the acid hydrolysate of 1–7, L-
2
3
4
. Sou, S.; Mayumi, S.; Takahashi, H.; Yamasaki, R.;
Kadoya, S.; Sodeoka, M.; Hashimoto, Y. Bioorg. Med.
Chem. Lett. 2000, 10, 1081–1084.
. (a) Frechet, D.; Christ, B.; De Sorbier, B. M.; Fischer, H.;
Vuilhorgne, M. Phytochemistry 1991, 30, 927–931; (b)
Larhsini, M.; Marston, A.; Hostettmann, K. Fitoterapia
2003, 74, 237–241.
arabinose, D-fucose, L-rhamnose, D-xylose, D-glucuronic
acid, D-galactose, and D-glucose were confirmed by
comparison of their retention times of their derivatives
with those of authentic L-arabinose (t 4.416 min), D-fu-
R
cose (t 4.573 min), L-rhamnose (t 5.086 min), D-xylose
R
R
(
tR 5.645 min), D-glucuronic acid (tR 6.613 min), D-gal-